Talking Biotech with Dr. Kevin Folta Immune Response to COVID19 and its Vaccines
The COVID19 vaccines have the potential to squelch a dangerous pandemic. However, the public has many questions about their safety and efficacy that could limit their broad administration. Some of the questions concern the immune system, how it is affected by the vaccine, why two doses are necessary, and if the response is durable. Today’s podcast interviews Dr. Asha Brunings about the immunology of the COVID vaccine and the disease itself.
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.